This 4-hour virtual workshop compares FDA, EU, MDSAP, NMPA, MFDS, and PMDA expectations, inspection trends, documentation requirements, and responses to findings, using case studies to strengthen global inspection readiness and compliance.
Upon the conclusion of the program, participants will be able to:
Basic: Content is introductory in nature and requires no requisite knowledge or experience to grasp concepts and related exercises. Basic educational activities are meant to establish a foundation of knowledge and/or competence that will be expanded upon in practice or in higher level activities.
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].





Director, Quality- Compliance & PMS, Shockwave Medical- Circulatory Restoration

USC Kim Center Advisory Committee - Department of Regulatory and Quality Sciences

Principal, China Med Device
Grace Fu Palma is the principal of China Med Device, part of the global market access platform, Accel Groups with offices in US, China and Japan. With representations in key countries, Accel Groups provides one-stop solutions for medical device/IVD companies to enter key countries market with regulatory, clinical, and commercial services. Grace is a seasoned bilingual and bicultural MedTech executive, specializing in China and US regulatory and commercialization services. She has 30 years of experience driving global and China business strategy, regulatory, clinical evaluation and trials, commercialization, partnerships, for both large multinationals and startup companies. She started China Med Device (CMD) in 2011. She has been personally involved in launching hundreds of medical devices in the US and China market. She has extensive network of clinical, regulatory and industry contacts. She founded Chinese American Heart Association in 2005 and Chinese Eye Care Alliance Group. She grew up in Beijing China with joint degree from Beijing University and an MBA from Yale University.
Global Program Director, Medical Devices, Business Assurance
Christine Forcier is a global leader in the medical device industry, serving as Global Director of Medical Devices at Intertek. Based in Montreal, Quebec, she brings extensive experience in quality, regulatory compliance, and certification services for medical technologies. Christine is known for driving strategic growth, fostering high-performing global teams, and working with organizations who want to bring safe products to market.

Regulatory Project Manager, China Med Device
Vicki Chen has 10 years of experience in China NMPA registration across medical devices, SaMD, and IVD products. She specializes in active and passive devices, cardiovascular technologies, and implantable products. Viki has led cross-region coordination of submission documentation between US/EU manufacturers and China local teams, covering type testing execution and NMPA submission deliverables. She has supported on-site NMPA testing at manufacturers’ sites for capital equipment, including IEC safety and EMC testing activities. Plus, she has experience in China Medical Device GMP-related factory audits/inspection readiness, including QMS documentation review, on-site compliance checks, and pre-inspection preparation support. Viki received her MBA from University of Illinois Urbana-Champaign (UIUC) and her BA from Sichuan University.
Principal Consultant, BCG Inc.
Jimin Choi is an experienced quality and regulatory compliance professional in the biopharmaceutical and medical device industries. He currently serves as Principal Consultant at BCG Inc. in South Korea, where he supports clients with Korean regulatory approval and market access projects.
He has extensive experience in quality management systems, GMP compliance, external manufacturing oversight, validation, regulatory submissions, audits, CAPA, change control, and risk management. Jimin has held quality leadership and specialist positions at leading pharmaceutical and biotechnology companies, including MSD and Novavax.
He is recognized for supporting manufacturing quality, strengthening CMO oversight, ensuring regulatory compliance, and helping organizations establish and maintain robust quality management systems for safe and compliant healthcare products.
At BCG Inc., he is responsible for managing clients’ Korean regulatory approval projects and has successfully supported more than 50 KGMP audits and assessments.

Director, Quality- Compliance & PMS, Shockwave Medical- Circulatory Restoration
Noemi Schambach is Director of Quality Compliance and Postmarket Surveillance at Shockwave Medical. She has more than 20 years of experience in the medical device industry, with extensive expertise in quality systems, regulatory compliance, postmarket surveillance, inspection readiness, and remediation.
Her experience includes oversight of quality systems for medical devices and combination products, regulatory compliance programs, and interactions with global regulatory authorities.
Noemi holds a Bachelor of Science in Chemistry from the University of California, Los Angeles. She is an ASQ Certified Quality Auditor, a certified Quality Management System Lead Auditor, and holds the Regulatory Affairs Certification for U.S. regulations.

USC Kim Center Advisory Committee - Department of Regulatory and Quality Sciences
Kimberly A. Trautman is an experienced Medical Devices, InVitro Diagnostics, and Combination Product Expert with over 40 years of experience. She worked at the US Food and Drug Administration (FDA) for over 24 years and continues to work with Regulatory Agencies around the globe. Industry experience as well as regulatory agency experience.
Kim is an expert in global medical device regulations, she authored and harmonized the 1996 US FDA Quality System Regulation and was on the international authoring group of ISO 13485 since inception and still today. While at FDA, she conceived and developed the Medical Device Single Audit Program (MDSAP) and its consortium of five Global Regulators. Kim was a twenty-year veteran of the Global Harmonization Tasks Force (GHTF) and foundational member of the International Medical Device Regulators Forum (IMDRF).
Kim has a demonstrated history of working collaboratively with industry, regulators, and patient groups for the betterment of public health. She has executed several medical device regulatory services and developed a formal Education/Training business. Established an Authorized Medical Device Single Audit Program (MDSAP) Auditing Organization and a new Notified Body for EU IVDR/MDR Designation.
Recognized International Medical Device expert with a Master's Degree in Biomedical Engineering.